Anna Weiss

The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS)

E. Shelley Hwang, Terry Hyslop, Thomas Lynch et al. · BMJ Open · 2019 · 307 citations · Full text

Medicine, Oncology, Surgery +14

Nodal Burden and Oncologic Outcomes in Patients With Residual Isolated Tumor Cells After Neoadjuvant Chemotherapy (ypN0i+): The OPBC-05/ICARO Study

Giacomo Montagna, Alison Laws, Massimo Ferrucci et al. · Journal of Clinical Oncology · 2024 · 42 citations · Full text

Medicine, Oncology, Chemotherapy +16

Patient-Reported Outcomes for Low-Risk Ductal Carcinoma In Situ

Ann H. Partridge, Terry Hyslop, Shoshana M. Rosenberg et al. · JAMA Oncology · 2024 · 15 citations · Full text

Medicine, Oncology, Surgery +13

Abstract PO4-19-05: OptimICE-pCR: De-escalation of therapy in early-stage TNBC patients who achieve pCR after neoadjuvant chemotherapy with checkpoint inhibitor therapy (Alliance A012103)

Sara M. Tolaney, Karla V. Ballman, Charles M. Perou et al. · Cancer Research · 2024 · 12 citations

Medicine, Oncology, Pharmacology +17

Incidence and treatments of DCIS in octogenarians: grade matters

Erin Ward, Anna Weiss, Sarah L. Blair · Breast Cancer Research and Treatment · 2017 · 11 citations

Medicine, Dermatology, Health Sciences +5